ENTITY

Biomarin Pharmaceutical (BMRN US)

61
Analysis
Health Care • United States
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
more
bullish•Shire PLC
•02 Jul 2018 17:41

Takeda/Shire II:  Drugs, Divvies, and AGM Votes

In Takeda/Shire I : On Drug Deals and Deckchairs I discussed the Drug Deal (the terms to the deal) and the Deckchairs - the significant reshuffling...

Logo
474 Views
Share
bullish•Chugai Pharmaceutical
•27 Aug 2017 18:04

Chugai Pharmaceutical (4519 JP): Emicizumab Gets PDUFA Data

Chugai Pharmaceutical (4519 JP) announced on August 24th that the US FDA has accepted its Biologics License Application (BLA) for emicizumab (emi)...

•02 Jun 2016 10:44

Equity Best Ideas

The Best Ideas list is a compilation of stock ideas sourced from Morningstar’s global equity research team.  Recent Asian additions: Allergan...

Share
x